Latest news
Loading news…
Xalud Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New York, United States Founded 2009 1-10 employees For Profit
Xalud Therapeutics is a biotech company that develops therapies for the treatment of neuro-inflammatory diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
14
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 26
- Active products
- 11
- IT spend
- $28K
Company Info
- Founded
- 2009
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 11
- HQ
- New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.3
- Trend (90d)
- -0.2
- Last leadership hire
- Nov 9, 2021
Key People at Xalud Therapeutics
Chief Medical Adviser
VP of Research and Development
14
professional contacts at Xalud Therapeutics
Contact execs at Xalud Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Xalud Therapeutics
Loading news…
FAQs about Xalud Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.